CONA
PDLI

Capital One National Association’s PDL BioPharma, Inc. PDLI Stock Holding History

Capital One National Association’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25,663
Closed -$198K – 615
2014
Q4 		$198K Buy
25,663
+1,097
+4% +$8.68K 0.02% 530
2014
Q3 		$184K Sell
24,566
-2,825
-10% -$26.2K 0.02% 509
2014
Q2 		$265K Sell
27,391
-152
-0.6% -$1.35K 0.02% 458
2014
Q1 		$229K Sell
27,543
-606
-2% -$5.19K 0.02% 501
2013
Q4 		$238K Buy
28,149
+12
+0% +$101 0.02% 496
2013
Q3 		$224K Buy
+28,137
New +$226K 0.02% 485

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Capital One National Association's PDLI Position: Q1 2015 in Review

Capital One National Association sold out of PDL BioPharma, Inc. (PDLI) in Q1 2015, closing a stake of 25,663 shares — an estimated $198K sold.

Capital One National Association first reported a position in PDLI in Q3 2013 and held it in 6 quarters. The position peaked at $265K in Q2 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

  • Capital One National Association reported no remaining PDL BioPharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • Capital One National Association sold 25,663 PDL BioPharma, Inc. shares in Q1 2015, an estimated $198K.
  • Capital One National Association first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 6 quarters.
  • Capital One National Association's PDL BioPharma, Inc. position peaked at $265K in Q2 2014.
  • 215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Capital One National Association's 13F filing for Q1 2015, filed 21 Apr 2015.